WHO – Page 17 – Communicable Diseases Research

Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test

현장 감시 검사로서 중화 항체 검출을 위한 SARS-CoV-2 신속 검사 키트의 진단 가치

Article

Published on 2022-04-272022-09-11
Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

The Mutual Influence of the World Health Organization (WHO) and Twitter Users During COVID-19: Network Agenda-Setting Analysis

Article

Published on 2022-04-262023-07-08
Journal: Journal of Medical Internet Research [Category] COVID19(2023년),

[키워드] agenda setting content analysis COVID-19 network agenda setting public health public opinion social media Twitter WHO
[DOI] 10.2196/34321 PMC 바로가기

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol

COVID-19 환자의 급성 신장 손상을 진단하기 위해 확장된 KDIGO 정의 사용: ISARIC-WHO 임상 특성화 프로토콜을 사용한 다국적 연구

Article

Published on 2022-04-202022-09-11
Journal: PLoS Medicine [Category] COVID19(2023년), SARS, 치료기술,

[키워드] 95% confidence interval Acute kidney injury acute respiratory syndrome ad hoc adjusted adjusted odds ratio Admission AKI analysed Analysis Care CCP characterisation Characteristics clinical Clinical characteristics Cohort collected Community coronavirus 2 coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) country COVID-19 creatinine death decrease detection rate diagnose diagnosed dialysis disease severity evaluated exclusion Final final analysis greater group Health Organization higher risk hospital Hospital admission hospitalisation hypothesised ICU ICU admission identify Improving In-hospital in-hospital complications In-hospital death incidence include increased mortality individual Infection International Severe Acute Respiratory and Emerging Infection Consortium interquartile range Invasive mechanical ventilation invasive ventilation KDIGO Kidney disease Kidney injury less limitation Logistic regression manifested Nephrology occurred organization outcome P-value Patient patients patients with AKI patients with COVID-19 patients without AKI peak problem proportion protocol recruited renal function reported respiratory SARS-CoV-2 serum creatinine Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus 2 significantly higher Society staging survival curve Survival curves susceptibility WHO
[DOI] 10.1371/journal.pmed.1003969 PMC 바로가기 [Article Type] Article

Misleading nomenclature of units of WHO materials used for standardization of SARS COv-2 serology

Article

Published on 2022-04-202023-07-08
Journal: Clinical chemistry and laboratory medicine [Category] COVID19(2023년),

[키워드] Certified reference material measurement unit. SARS CoV-2 antibody WHO
[DOI] 10.1515/cclm-2022-0082

Surveillance to Track Progress Toward Polio Eradication – Worldwide, 2020-2021

소아마비 퇴치를 향한 진행 상황을 추적하기 위한 감시 - 전 세계, 2020-2021

Article

Published on 2022-04-152022-09-11
Journal: Morbidity and Mortality Weekly Report [Category] 바이오마커, 치료기술, 치료제, 폴리오,

Health and science-related disinformation on COVID-19: A content analysis of hoaxes identified by fact-checkers in Spain

COVID-19에 대한 건강 및 과학 관련 허위 정보: 스페인의 팩트 체커가 식별한 사기에 대한 콘텐츠 분석

Article

Published on 2022-04-132022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 치료기술,

WHO Standards-based questionnaire to measure health workers’ perspective on the quality of care around the time of childbirth in the WHO European region: development and mixed-methods validation in six countries

Article

Published on 2022-04-082022-10-05
Journal: BMJ Open [Category] 임상,

Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study

입원한 COVID-19 환자의 집중 용량 Tinzaparin: INTERACT 연구

Observational Study

Published on 2022-04-072022-09-12
Journal: Viruses [Category] COVID19(2023년), SARS, 임상, 진단,

[키워드] Activation Administered Admission adverse outcome anticoagulation bleeding event clinical clinical effectiveness coagulation cascade coronavirus COVID-19 COVID-19 patient CRP levels current D-dimer D-dimer level death Deep venous thrombosis diagnosed discharge dose DVT evaluate favor Greece hospital Hospitalized hospitalized COVID-19 patient hypercoagulability increasing age initiated intermediate dose Laboratory low molecular weight Low molecular weight heparins median age median treatment duration men moderate disease Mortality non-critically ill patient Observational cohort study occurred oxygen saturation participant participated Patient pharmacological Platelet pro-inflammatory progression Prophylactic prophylactic dose Prophylaxis receive retrospective SARS-CoV-2 severity therapeutic Thromboprophylaxis thrombosis thrombotic event tinzaparin tinzaparin. Venous Thromboembolism VTE were recorded WHO with COVID-19 World Health Organization
[DOI] 10.3390/v14040767 PMC 바로가기 [Article Type] Observational Study

Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis

Research article

Published on 2022-04-072022-10-05
Journal: EClinicalMedicine [Category] 치료제,

[키워드] 95% confidence interval acute respiratory syndrome administration Admission adverse outcome adverse outcomes Analysis article Aspirin association Biology can be used China Cochrane Library conducted coronavirus COVID-19 COVID-19 pandemic death did not reduce enrolled Evidence finding funding funding source Google Scholar higher risk ICU increased risk Infrastructure inhibitor intensive care mechanical ventilation Medicine Meta-analysis methodology Mortality non-steroidal anti-inflammatory drug NSAID NSAIDS Odds ratio outcome Patient people with COVID-19 positive Probability Research Result risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 tests selected significantly stratified subgroup analysis suggested supplemental oxygen systematic review Web of Science WHO
[DOI] 10.1016/j.eclinm.2022.101373 [Article Type] Research article

COVID-19 seroprevalence in Pakistan: a cross-sectional study

파키스탄의 COVID-19 혈청 유병률: 단면 연구

Article

Published on 2022-04-062022-09-12
Journal: BMJ Open [Category] COVID19(2023년), SARS, 진단,

[키워드] age antibody conducted confirmed COVID-19 case Contact contraindication country COVID-19 cross-sectional eligible Epidemiology estimate exclusion female females Gender General population Gilgit group IgG IgM immunity pattern individual information male MONITOR no significant difference outcome measures Population population level population prevalence positive proportion protocol provide public health ranged replicated risk risk factor SARS CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection secondary outcome Seroprevalence similar study study participant the disease venipuncture were measured WHO
[DOI] 10.1136/bmjopen-2021-055381 PMC 바로가기 [Article Type] Article